Surface display of p75, a Lactobacillus rhamnosus GG derived protein, on Bacillus subtilis spores and its antibacterial activity against Listeria monocytogenes
- PMID: 32770428
- PMCID: PMC7415045
- DOI: 10.1186/s13568-020-01073-9
Surface display of p75, a Lactobacillus rhamnosus GG derived protein, on Bacillus subtilis spores and its antibacterial activity against Listeria monocytogenes
Abstract
Lactobacillus rhamnosus p75 protein with peptidoglycan hydrolase (PGH) activity is one of the key molecules exhibiting anti-apoptotic and cell-protective activity for human intestinal epithelial cells. In this study, with the goal of developing new probiotics, the p75 protein was displayed on the surface of Bacillus subtilis spores using spore coat protein CotG as an anchoring motif. The PGH activity, stability, and the antibacterial activity of the spore-displayed p75 (CotG-p75) protein were also investigated. The PGH activity of the CotG-p75 against peptidoglycan extracted from B. subtilis was confirmed by the ninhydrin test. Under various harsh conditions, compared to the control groups, the PGH activities of CotG-p75 were very stable in the range of pH 3-7 and maintained at 70% at 50 °C. In addition, the antibacterial activity of CotG-p75 against Listeria monocytogenes was evaluated by a time-kill assay. After 6 h incubation in phosphate-buffered saline, CotG-p75 reduced the number of viable cells of L. monocytogenes by up to 2.0 log. Scanning electron microscopy analysis showed that the cell wall of L. monocytogenes was partially damaged by the treatment with CotG-p75. Our preliminary results show that CotG-p75 could be a good candidate for further research to develop new genetically engineered probiotics.
Keywords: Antibacterial activity; L. monocytogenes; Spore surface display; p75 protein.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





References
-
- Barry AL, Craig WC, Nadler H, Reller LB, Sanders CC, Swenson JM (1999) Methods for determining bactericidal activity of antimicrobial agents; approved guideline. NCCLS document M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials